Looking Beyond Mammals to Microbes for Tomorrow’s Drugs

(DGIwire) – In order to create the current generation of biologic drugs, manufacturers have largely depended on cell lines derived from mammals—specifically, the Chinese hamster ovary (CHO) cell. But as Mark Emalfarb, President and CEO of Dyadic International, wrote recently on TheMedicineMaker.com, it may be time to move from mammals to microbes for the next […]

Is a Fungus Among Us the Key to Tomorrow’s Biologic Drugs?

(DGIwire) – If the word “fungus” stirs up nothing but unpleasant thoughts, it might be time to reconsider. Recall that a fungal organism was instrumental to the serendipitous discovery of the first true antibiotic, penicillin. In 1928, as Healio.com notes, Sir Alexander Fleming returned from a two-week vacation to find that a mold had developed […]

Seniors & Drugs: An Abuse Epidemic

(DGIwire) — When we think about drug addiction, seniors are certainly not the first age group that comes to mind. But here’s the reality: one quarter of the prescription drugs sold in the United States are used by the elderly, often for problems such as chronic pain, insomnia and anxiety, according to ModernMedicine.com. According to […]

close